Detection of Laminin 5-Specific Auto-antibodies in Mucous Membrane and Bullous Pemphigoid Sera by ELISA  Vassiliki Bekou, Sybille Thoma-Uszynski, Olaf.

Slides:



Advertisements
Similar presentations
Journal of Allergy and Clinical Immunology
Advertisements

TWEAK/Fn14 Activation Contributes to the Pathogenesis of Bullous Pemphigoid  Yale Liu, Lingling Peng, Liang Li, Chengfei Liu, Xiao Hu, Shengxiang Xiao,
Volume 69, Issue 1, Pages (January 2006)
IgG from Patients with Bullous Pemphigoid Depletes Cultured Keratinocytes of the 180- kDa Bullous Pemphigoid Antigen (Type XVII Collagen) and Weakens Cell.
Volume 66, Issue 1, Pages (July 2004)
The Autoantigen in Anti-p200 Pemphigoid Is Synthesized by Keratinocytes and Fibroblasts and Is Distinct from Nidogen-2  Silke C. Hofmann, Ursula Voith,
The Autoantigen of Anti-p200 Pemphigoid Is an Acidic Noncollagenous N-Linked Glycoprotein of the Cutaneous Basement Membrane  Iakov Shimanovich, Yoshiaki.
Epidermolysis Bullosa Acquisita Develops in Dominant Dystrophic Epidermolysis Bullosa  Ryota Hayashi, Ken Natsuga, Mika Watanabe, Hiroaki Iwata, Satoru.
Bullous Allergic Hypersensitivity to Bed Bug Bites Mediated by IgE against Salivary Nitrophorin  Martin Leverkus, Ryan C. Jochim, Susanne Schäd, Eva-Bettina.
Bullous Pemphigoid Sera that Contain Antibodies to BPAg2 also Contain Antibodies to LABD97 that Recognize Epitopes Distal to the NC16A Domain  Conleth.
A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180  Manabu Osawa, MD, Ikuko Ueda-Hayakawa, MD, PhD, Taiki.
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
Refractory oral ulcers with multiple immunoglobulin G/immunoglobulin A autoantibodies without skin lesions  Teruki Dainichi, MD, Bungo Ohyama, MD, Norito.
Loss of the Desmosomal Protein Perp Enhances the Phenotypic Effects of Pemphigus Vulgaris Autoantibodies  Bichchau Nguyen, Rachel L. Dusek, Veronica G.
Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in.
Expression of Multiple Cytochrome P450 Enzymes and Multidrug Resistance- Associated Transport Proteins in Human Skin Keratinocytes  Jens M. Baron, Daniela.
Masamoto Murakami, Takaaki Ohtake, Robert A. Dorschner, Richard L
Mechanism of microthrombosis in HUS
Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment.
Component-Resolved Diagnosis (CRD) of Type I Allergy with Recombinant Grass and Tree Pollen Allergens by Skin Testing  Susanne Heiss, Rudolf Valenta 
Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis  Huijie Yuan, Shengru Zhou, Zhicui Liu, Weiting Cong, Xiaochun Fei,
The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies  Anika Kasprick, Maike M. Holtsche,
Paraneoplastic Pemphigus Sera React Strongly with Multiple Epitopes on the Various Regions of Envoplakin and Periplakin, Except for the C-Terminal Homologous.
Protein C Inhibitor is Expressed in Keratinocytes of Human Skin
Localization of Rat FGF-5 Protein in Skin Macrophage-like Cells and FGF-5S Protein in Hair Follicle: Possible Involvement of twoFgf-5 Gene Products in.
Autoantibodies in a Subgroup of Patients with Linear IgA Disease React with the NC16A Domain of BP1801  Detlef Zillikens, Karin Herzele, Matthias Georgi,
Evidence that Anti-Type VII Collagen Antibodies Are Pathogenic and Responsible for the Clinical, Histological, and Immunological Features of Epidermolysis.
Localization of the Laminin α4 Chain in the Skin and Identification of a Heparin- Dependent Cell Adhesion Site Within the Laminin α4 Chain C-Terminal LG4.
Expression of Matrilin-2 in Human Skin
Characterization of the Anti-BP180 Autoantibody Reactivity Profile and Epitope Mapping in Bullous Pemphigoid Patients1  Giovanni Di Zenzo, Fabiana Grosso,
Autoantibodies to Bullous Pemphigoid Antigen 180 Induce Dermal–Epidermal Separation in Cryosections of Human Skin  Cassian Sitaru, Enno Schmidt, Steffen.
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
Detection of IgG Autoantibodies in the Sera of Patients with Bullous and Gestational Pemphigoid: ELISA Studies Utilizing a Baculovirus-Encoded Form of.
Epitope Spreading: Lessons From Autoimmune Skin Diseases
Prevalence of Antibodies Against Virus-Like Particles of Epidermodysplasia Verruciformis-Associated HPV8 in Patients at Risk of Skin Cancer  Sabine Stark,
BP230- and BP180-specific Auto-Antibodies in Bullous Pemphigoid
FGF Expression Allows Nevus Cells to Survive in Three-Dimensional Collagen Gel Under Conditions that Induce Apoptosis in Normal Human Melanocytes  Tuomo.
Arsenic Induces Tumor Necrosis Factor α Release and Tumor Necrosis Factor Receptor 1 Signaling in T Helper Cell Apoptosis  Hsin-Su Yu, Gwo-Shing Chen 
Identification of a Potential Effector Function for IgE Autoantibodies in the Organ- Specific Autoimmune Disease Bullous Pemphigoid  Otobia G. Dimson,
TWEAK/Fn14 Activation Contributes to the Pathogenesis of Bullous Pemphigoid  Yale Liu, Lingling Peng, Liang Li, Chengfei Liu, Xiao Hu, Shengxiang Xiao,
Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid  Kentaro Izumi, Wataru Nishie, Yosuke Mai, Mayumi Wada,
The Members of the Plakin Family of Proteins Recognized by Paraneoplastic Pemphigus Antibodies Include Periplakin  My G. Mahoney, Sirpa Aho, Jouni Uitto,
Masaki Nagai, Minoru Hasegawa, Kazuhiko Takehara, Shinichi Sato 
Erythema Multiforme Associated Human Autoantibodies Against Desmoplakin I and II: Biochemical Characterization and Passive Transfer Studies Into Newborn.
The Intracellular and Extracellular Domains of BP180 Antigen Comprise Novel Epitopes Targeted by Pemphigoid Gestationis Autoantibodies  Giovanni Di Zenzo,
Increased Blood Levels of IgG Reactive with Secreted Streptococcus pyogenes Proteins in Chronic Plaque Psoriasis  Rana G. El-Rachkidy, Jonathan M. Hales,
Serum IgE Autoantibodies Target Keratinocytes in Patients with Atopic Dermatitis  Sabine Altrichter, Ernst Kriehuber, Julia Moser, Rudolf Valenta, Tamara.
Apolipoprotein E is Present in Primary Localized Cutaneous Amyloidosis
IgG Autoantibodies from Bullous Pemphigoid (BP) Patients Bind Antigenic Sites on Both the Extracellular and the Intracellular Domains of the BP Antigen.
Anti-Alpha-2-Macroglobulin-Like-1 Autoantibodies Are Detected Frequently and May Be Pathogenic in Paraneoplastic Pemphigus  Sanae Numata, Kwesi Teye,
Volume 64, Issue 3, Pages (September 2003)
Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF- induced mesangial cell migration  Kim Hansen, Christine K. Abrass 
The Prevalence and Clinical Significance of Anti-U1 RNA Antibodies in Patients with Systemic Sclerosis  Yoshihide Asano, Hironobu Ihn, Kenichi Yamane,
Expression of Opsin Molecule in Cultured Murine Melanocyte
Production of Low Titers of Anti-Desmoglein 1 IgG Autoantibodies in Some Patients with Staphylococcal Scalded Skin Syndrome  Hidemi Anzai, John R. Stanley,
Autoantibody in Mucous Membrane Pemphigoid Binds to an Intracellular Epitope on Human β4 Integrin and Causes Basement Membrane Zone Separation in Oral.
Fig. 2. Sera IgE reactivity patterns and the frequency of reactivity to raw and cooked shrimp extracts by Western blot. (A, C) All sera were diluted at.
Autoantibodies to BP180 Associated with Bullous Pemphigoid Release Interleukin-6 and Interleukin-8 from Cultured Human Keratinocytes  Enno Schmidt, Stanislaus.
IgG Autoantibodies from Bullous Pemphigoid Patients Recognize Multiple Antigenic Reactive Sites Located Predominantly Within the B and C Subdomains of.
Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer’s Disease  Nina Kokkonen, Sanna-Kaisa.
Janet A. Fairley, Chang Ling Fu, George J. Giudice 
Severity and Phenotype of Bullous Pemphigoid Relate to Autoantibody Profile Against the NH2- and COOH-Terminal Regions of the BP180 Ectodomain  Silke.
Flor Evangelista, David A. Dasher, Luis A. Diaz, Phillip S
A Subset of Pemphigus Foliaceus Patients Exhibits Pathogenic Autoantibodies Against Both Desmoglein-1 and Desmoglein-3  Luis A. Arteaga, Philip S. Prisayanh,
The IgE-Reactive Autoantigen Hom s 2 Induces Damage of Respiratory Epithelial Cells and Keratinocytes via Induction of IFN-γ  Irene Mittermann, Renate.
Coexpression of Integrin αvβ3 and Matrix Metalloproteinase-2 (MMP-2) Coincides with MMP-2 Activation: Correlation with Melanoma Progression  Uta B. Hofmann,
IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid  Zelmira Lazarova, MD, Valerie.
Zhuxiang Nie, Takashi Hashimoto  Journal of Investigative Dermatology 
Matrix Metalloproteinase Inhibitor BB-3103 Unlike the Serine Proteinase Inhibitor Aprotinin Abrogates Epidermal Healing of Human Skin Wounds Ex Vivo1 
Clusterin Gene Expression Mediates Resistance to Apoptotic Cell Death Induced by Heat Shock and Oxidative Stress  Isabelle Viard, Philippe Wehrli, Lan.
Presentation transcript:

Detection of Laminin 5-Specific Auto-antibodies in Mucous Membrane and Bullous Pemphigoid Sera by ELISA  Vassiliki Bekou, Sybille Thoma-Uszynski, Olaf Wendler, Wolfgang Uter, Susanne Schwietzke, Thomas Hunziker, Christos C. Zouboulis, Gerold Schuler, Lydia Sorokin, Michael Hertl  Journal of Investigative Dermatology  Volume 124, Issue 4, Pages 732-740 (April 2005) DOI: 10.1111/j.0022-202X.2005.23646.x Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 (A, B) Affinity-purified laminin 5 (LN5). (A) Silver stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels run under reducing conditions of LN5 from SCC-25 cell culture media, before and after affinity purification from culture supernatants. (B) Mouse anti-LN α3, goat anti-LN β3, and mouse anti-LN γ2, all showed reactivity with the purified LN5 preparation. The bands shown represent the normal unprocessed and processed forms of the LN5 chains. α3 chain, processed at 165 kDa; β3 chain, unprocessed at 140 kDa; and γ2 chain, unprocessed at 155 kDa and processed at 105 kDa. The content of residual fibronectin (FN) in the LN5 preparation was visualized by a goat anti-FN ab. Numbers on the left of the gels indicate migration positions of molecular weight marker. Journal of Investigative Dermatology 2005 124, 732-740DOI: (10.1111/j.0022-202X.2005.23646.x) Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 (A–C) Sensitivity and specificity of the laminin 5 (LN5) ELISA. The diagnostic properties of the LN5 ELISA are depicted as receiver operating characteristic curves for (A) mucous membrane pemphigoid (MMP) and (B) bullous pemphigoid (BP) sera. Sera of patients with active MMP (n=24), BP (n=72), and controls (n=51) were screened for LN5 IgG reactivity by ELISA. (C) Comparing the IgG reactivity against LN5 in the MMP, BP, and control sera, a significant difference in the LN5 IgG autoantibody status was found between all three groups in pairwise tests. Journal of Investigative Dermatology 2005 124, 732-740DOI: (10.1111/j.0022-202X.2005.23646.x) Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 (A, B) Anti-laminin 5 (LN5) reactivity of the mucous membrane pemphigoid (MMP) and bullous pemphigoid (BP) sera by dot blot analysis. (A) A total of 24 MMP, 72 BP, and 51 control sera were analyzed for LN5 IgG reactivity by dot blot. 14/24 (58.3%) MMP and 16/72 (22.2%) BP sera reacted with LN5 by dot blot analysis. Representative dots of the LN5-reactive patients' and control sera are shown. Fibronectin (FN) was used as a control protein. (B) The clinical phenotype of the LN5-reactive MMP and BP patients is depicted. Journal of Investigative Dermatology 2005 124, 732-740DOI: (10.1111/j.0022-202X.2005.23646.x) Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 Immunoserological profile of mucous membrane pemphigoid (MMP) and bullous pemphigoid (BP) patients. The IgG reactivity pattern of MMP and BP sera with saline-split human skin (SSS) compared with IgG reactivity to laminin 5 (LN5) by ELISA and dot blot analysis are shown. A significant portion of the 13 SSS-negative MMP sera and eight SSS-negative BP sera were reactive for LN5 by ELISA or dot blot analysis. Journal of Investigative Dermatology 2005 124, 732-740DOI: (10.1111/j.0022-202X.2005.23646.x) Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 (A, B) IgG titers against laminin 5 (LN5) correlate with the clinical severity of mucous membrane pemphigoid (MMP) but not of bullous pemphigoid (BP). (A) MMP patients with extensive skin involvement had higher LN5-specific IgG autoantibody levels than MMP patients with limited or exclusive mucous membrane involvement. (B) In contrast, anti-LN5 IgG reactivity of the BP sera did not show such a relationship with the clinical status (ns, not significant). Journal of Investigative Dermatology 2005 124, 732-740DOI: (10.1111/j.0022-202X.2005.23646.x) Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 6 (A–C) Anti-laminin 5 (LN5) IgG titers correlate with disease activity in a patient with mucous membrane pemphigoid (MMP). The clinical phenotype of a MMP patient (A) over a course of 120 wk and corresponding serum IgG reactivity to LN5 by ELISA (B) and by dot blot analysis (C) are shown. Remarkably, upon clinical remission the titers of LN5-reactive IgG declined to threshold levels. Journal of Investigative Dermatology 2005 124, 732-740DOI: (10.1111/j.0022-202X.2005.23646.x) Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 7 (A, B) Relationship of IgG reactivity for laminin 5 (LN5) and bullous pemphigoid (BP)180 or BP230 of mucous membrane (MMP) and BP sera. A total of 6/24 (25.0%) of the MMP sera were reactive to BP180, four of which (16.7%) showed IgG reactivity to LN5 (A). Among the BP sera, 55/72 (76.4%) were positive for BP180 and 34/72 (47.2%) for BP230. A total of 22/72 (30.6%) of the BP180-reactive BP sera were also LN5 reactive and 12/72 (16.7%) of the BP230-positive BP sera showed IgG reactivity to LN5 (B) (ns, not significant). Journal of Investigative Dermatology 2005 124, 732-740DOI: (10.1111/j.0022-202X.2005.23646.x) Copyright © 2005 The Society for Investigative Dermatology, Inc Terms and Conditions